Specific Challenges in Treating Breast Cancer in Pregnant Women

References

• Aha BY , KimHH, MoonWKet al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J. Ultrasound Med.22, 491–497 (2003).
   PubMed Web of Science ®Google Scholar
• Woo JC , YuT, HurdTC. Breast cancer in pregnancy: a literature review. Arch. Surg.138, 91–98 (2003).
   PubMedGoogle Scholar
• Ishida T , YokoeT, KasumiFet al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case–control study in Japan. Jpn J. Cancer Res.83, 1143–1149 (1992).
   PubMedGoogle Scholar
• Nettleton J , LongJ, KuhanD, WuR, ShaefferJ, El-MahdiA. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet. Gynecol.87, 414–418 (1996).
   PubMed Web of Science ®Google Scholar
• Wojcinski S , StefanidouN, HillemansP, DegenhardtF. The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases. BMC Womens Health13, 47 (2013).
   PubMed Web of Science ®Google Scholar
• Prenatal Radiation Exposure: A Fact Sheet for Physicians (CDC) .www.bt.cdc.gov/radiation/prenatalphysician.asp.
   Google Scholar
• Petrek JA , DukoffR, RogatkoA. Prognosis of pregnancy-associated breast cancer. Cancer67, 869–872 (1991).
   PubMed Web of Science ®Google Scholar
• Zemlickis D , LishnerM, DegendorferPet al. Maternal and fetal outcomes after breast cancer in pregnancy. Am. J. Obstet. Gynecol.166, 781–787 (1992).
   PubMed Web of Science ®Google Scholar
• Halaska MJ , PentheroudakisG, StrnadPet al. Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J.15, 461–467 (2009).
   PubMed Web of Science ®Google Scholar
• Ibrahim EM , EzzatAA, BaloushA, HussainZH, MohammedGH. Pregnancy-associated breast cancer: a case–control study in a young population with a high-fertility rate. Med. Oncol.17, 293–300 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang J , LiuG, WuJet al. Pregnancy-associated breast cancer: a case control and long-term follow-up study in China. J. Exp. Clin. Cancer Res.22, 23–27 (2003).
   PubMed Web of Science ®Google Scholar
• Smith LH , DanielsenB, AllenME, CressM. Cancer associated with obstetric delivery: results of linkage with the California Cancer Registry. Am. J. Obstet. Gynecol.189, 1128–1135 (2003).
   PubMed Web of Science ®Google Scholar
• Nugent P , O’ConnellTX. Breast cancer and pregnancy. Arch. Surg.120, 1221–1224 (1985).
   PubMedGoogle Scholar
• Azim HA Jr , SantoroL, Russell-EduW, PentheroudakisG, PavlidisN, PeccatoriFA. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat. Rev.38, 834–842 (2012).
   PubMed Web of Science ®Google Scholar
• Johansson AL , AnderssonTM, HsiehCCet al. Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC). Breast Cancer Res. Treat.139, 183–192 (2013).
   PubMed Web of Science ®Google Scholar
• Amant F , von MinckwitzG, HanSNet al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J. Clin. Oncol.31, 2532–2540 (2013).
   PubMed Web of Science ®Google Scholar
• Amant F , DeckersS, Van CalsterenKet al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur. J. Cancer46, 3158–3168 (2010).
   PubMed Web of Science ®Google Scholar
• Pavlidis N , PentheroudakisG. The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat. Rev.31, 439–447 (2005).
   PubMed Web of Science ®Google Scholar
• Bonnier P , RomainS, Dilhuydy, JMet al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int. J. Cancer72, 720–727 (1997).
   PubMed Web of Science ®Google Scholar
• Shousha S . Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch. Pathol. Lab. Med.124, 1053–1060 (2000).
   PubMed Web of Science ®Google Scholar
• Middleton LP , AminM, GwynK, TheriaultR, SahinA. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer98, 1055–1060 (2003).
   PubMed Web of Science ®Google Scholar
• Reed W , SandstadB, HolmR, NeslandJM. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int. J. Surg. Pathol.11, 65–74 (2003).
   PubMed Web of Science ®Google Scholar
• Elledge RM , CioccaDR, LangoneG, McGuireWL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer71, 2499–2506 (1993).
   PubMed Web of Science ®Google Scholar
• Loibl S , von MinckwitzG, GwynKet al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer106, 237–46 (2006).
   PubMed Web of Science ®Google Scholar
• Psyrri A , BurtnessB. Pregnancy-associated breast cancer. Cancer J.11, 83–95 (2005).
   PubMed Web of Science ®Google Scholar
• King RM , WelchJS, MartinJKJr, CoulamCB. Carcinoma of the breast associated with pregnancy. Surg. Gynecol. Obstet.160, 228–232 (1985).
   PubMedGoogle Scholar
• Clark RM . Breast cancer and pregnancy: the ultimate challenge. Clin. Oncol.1, 11–18 (1989).
   PubMedGoogle Scholar
• Jacobs IA , ChangCK, SaltiGI. Coexistence of pregnancy and cancer. Am. Surg.70, 1025–1029 (2004).
   PubMed Web of Science ®Google Scholar
• Henry M , HuangLN, SprouleBJ, CardonickE. The psychological impact of a cancer diagnosis during pregnancy: determinants of long term distress. Psychooncology21(4), 444–450 (2014).
   Web of Science ®Google Scholar
• Beadle BM , WoodwardW, MiddletonLPet al. The impact of pregnancy on breast cancer outcomes in women < or =35 years. Cancer115, 1174–1184 (2009).
   PubMed Web of Science ®Google Scholar
• Kuerer HM , GwynK, AmesFC, TheriaultRL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery131, 108–110 (2002).
   PubMed Web of Science ®Google Scholar
• Gropper AB , CalvilloKZ, DominiciLet al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann. Surg. Oncol.21(8), 2506–2511 (2014).
   PubMed Web of Science ®Google Scholar
• Gentilini O , CremonesiM, ToescaAet al. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur. J. Nucl. Med. Mol. Imaging37, 78–83 (2010).
   PubMed Web of Science ®Google Scholar
• Pandit-Taskar N , DauerLT, MontgomeryL, St GermainJ, ZanzonicoPB, DivgiCR. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J. Nucl. Med.47, 1202–1208 (2006).
   PubMed Web of Science ®Google Scholar
• Cinar H , KocaB, KesiciogluTet al. Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer. Breast21(2), 220–222 (2012).
   PubMed Web of Science ®Google Scholar
• Crooks J . Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue. Arch. Dis. Child.57, 872–873 (1982).
   PubMed Web of Science ®Google Scholar
• Berry DL , TheriaultRL, HolmesFAet al. Management of breast cancer during pregnancy using a standardized protocol. J. Clin. Oncol.17, 855–861 (1999).
   PubMed Web of Science ®Google Scholar
• Hahn KM , JohnsonPH, GordonNet al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer107, 1219–1226 (2006).
   PubMed Web of Science ®Google Scholar
• Aviles A , NeriN. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin. Lymphoma2(3), 173–177 (2001).
   PubMedGoogle Scholar
• Amant F , Van CalsterenK, HalaskaMet al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol.13, 256–264 (2012).
   PubMed Web of Science ®Google Scholar
• Rouzier R , WerkoffG, UzanCet al. Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting. Ann. Oncol.22, 1582–1587 (2011).
   PubMed Web of Science ®Google Scholar
• Laurentiis M , CancelloG, D’AgostinoDet al. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J. Clin. Oncol.26, 44–53 (2008).
   PubMed Web of Science ®Google Scholar
• Martin M , PienkowskiT, MackeyJet al. Adjuvant docetaxel for node-positive breast cancer. N. Engl. J. Med.352, 2302–2313 (2005).
   PubMed Web of Science ®Google Scholar
• Sparano JA , WangM, MartinoSet al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N. Engl. J. Med.358, 1663–1671 (2008).
   PubMed Web of Science ®Google Scholar
• Jones S , HolmesFA, O’ShaughnessyJet al. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735. J. Clin. Oncol.27, 1177–1183 (2009).
   PubMed Web of Science ®Google Scholar
• Cardonick E , BhatA, GilmandyarD, SomerR. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann. Oncol.30, 16–23 (2012).
   Google Scholar
• Sood AK , ShahinMS, SoroskyJI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol. Oncol.83, 599–600 (2001).
   PubMed Web of Science ®Google Scholar
• Mendez LE , MuellerA, SalomE, González-QuinteroVH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet. Gynecol.102, 1200–1202 (2003).
   PubMed Web of Science ®Google Scholar
• Rouzi AA , SahlyNN, SahlyNF, AlahwalMS. Cisplatinum and docetaxel for ovarian cancer in pregnancy. Arch. Gynecol. Obstet.280, 823–825 (2009).
   PubMed Web of Science ®Google Scholar
• Chun KC , KimDY, KimJH, KimYM, KimYT, NamJH. Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. Jpn J. Clin. Oncol.40, 694–698 (2010).
   PubMed Web of Science ®Google Scholar
• García-González J , CuevaJ, LamasMJ, CurielT, GrañaB, López-LópezR. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy. Clin. Transl. Oncol.10, 375–376 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JH , KimHS, SungCW, KimKJ, KimCH, LeeKY. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung Cancer59, 270–273 (2008).
   PubMed Web of Science ®Google Scholar
• Azim HA , ScarfoneG, PeccatoriFA. Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy. J. Thorac. Oncol.4, 559–560 (2009).
   PubMedGoogle Scholar
• Mir O , BerveillerP, GoffinetFet al. Taxanes for breast cancer during pregnancy: a systematic review. Ann. Oncol.21, 425–6 (2010).
   PubMed Web of Science ®Google Scholar
• Serkies K , We˛GrzynowiczE, JassemJ. Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature. Arch. Gynecol. Obstet.283(Suppl. 1), 97–100 (2011).
   PubMedGoogle Scholar
• Cardonick E , GilmandyarD, SomerR. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet. Gynecol.120(6), 1267–1272 (2012).
   PubMed Web of Science ®Google Scholar
• Peccatori FA , AzimHAJr, ScarfoneGet al. Weekly epirubicin in the treatment of gestational breast cancer. Breast Cancer Res. Treat.115, 591–594 (2009).
   PubMed Web of Science ®Google Scholar
• Van Calsteren K , VerbesseltR, OttevangerNet al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstetr. Gynecol. Scand.89(10), 1338–45 (2010).
   PubMed Web of Science ®Google Scholar
• Azim HA Jr , Del MastroL, ScarfoneGet al. Treatment of breast cancer during pregnancy: regimen selection, pregnancy monitoring and more… Breast 20, 1–6 (2011).
   PubMed Web of Science ®Google Scholar
• Sekar R , StonePR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet. Gynecol.110, 507–510 (2007).
   PubMed Web of Science ®Google Scholar
• Shrim A , Garcia-BournissenF, MaxwellC, FarineD, KorenG. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy – case report and updated literature review. Reprod. Toxicol.23, 611–613 (2007).
   PubMed Web of Science ®Google Scholar
• Bader AA , SchlembachD, TamussinoKF, PristauzG, PetruE. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol.8, 79–81 (2007).
   PubMed Web of Science ®Google Scholar
• Waterston AM , GrahamJ. Effect of adjuvant trastuzumab on pregnancy. J. Clin. Oncol.24, 321–322 (2006).
   PubMed Web of Science ®Google Scholar
• Fanale MA , UyeiAR, TheriaultRL, AdamK, ThompsonRA. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin. Breast Cancer6, 354–356 (2005).
   PubMedGoogle Scholar
• Watson WJ . Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet. Gynecol.105, 642–643 (2005).
   PubMed Web of Science ®Google Scholar
• Azim HA Jr , PeccatoriFA, LiptrottSJ, CataniaC, GoldhirschA. Breast cancer and pregnancy: how safe is trastuzumab?Nat. Rev. Clin. Oncol.6, 367–370 (2009).
   PubMed Web of Science ®Google Scholar
• Beale JM , TuohyJ, McDowellSJ. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am. J. Obstet. Gynecol.201, e13–e14 (2009).
   PubMed Web of Science ®Google Scholar
• Weber-Schoendorfer C , SchaeferC. Trastuzumab exposure during pregnancy. Reprod. Toxicol.25, 390–391; author reply 392 (2008).
   PubMed Web of Science ®Google Scholar
• Pant S , LandonMB, BlumenfeldM, FarrarW, ShapiroCL. Treatment of breast cancer with trastuzumab during pregnancy. J. Clin. Oncol.26, 1567–1569 (2008).
   PubMed Web of Science ®Google Scholar
• Zagouri F , SergentanisTN, ChrysikosD, PapadimitriouCA, DimopoulosMA, BartschR. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res. Treat.137, 349–357 (2013).
   PubMed Web of Science ®Google Scholar
• Antypas C , SandilosP, KouvarisJet al. Fetal dose evaluation during breast cancer radiotherapy. Int. J. Radiat. Oncol. Bio. Phys.40, 995–999 (1998).
   PubMed Web of Science ®Google Scholar